Prostate cancer changes in clinical presentation and treatments in two decades: an Italian population-based study

Annalisa Trama, Laura Botta, Nicola Nicolai, Paolo Giorgi Rossi, Paolo Contiero, M. Fusco, Michele Lodde, F. Pannozzo, S. Piffer, Antonella Puppo, Andreas Seeber, Rosario Tumino, Riccardo Valdagni, Gemma Gatta

Research output: Contribution to journalArticle

Abstract

Introduction The incidence of prostate cancer is on the rise in many industrialised countries, including Italy, most likely because of the spread of PSA testing. In Italy, prostate cancer mortality has been dropping since 2000, but it is difficult to understand whether PSA testing is the main reason, considering the role of treatment in prognosis. The objectives of this study were: (1) to describe Italian trends of prostate cancer risk categories and corresponding changes in treatment patterns and (2) to interpret changes in survival over time. Methods We made a retrospective observational study using population-based cancer registries. We examined two periods, 1996–1999 and 2005–2007, analysing the distribution of patients among risk groups and treatment changes in those intervals. We estimated 7- and 15-year relative survival with the cohort approach, Ederer II method. We analysed 4635 cases. Results There was downward risk migration from the first to the second period. In patients younger than 75 years, there was an increase in radical prostatectomy but not radiotherapy; patients older than 75 years rarely had treatment with radical intent. We noted an improvement of prostate cancer survival in the high-risk group. Conclusion These findings raise several questions: the possible overtreatment of low-risk patients undergoing radical treatment; the utility of more aggressive treatment for elderly patients with high-risk disease; and the importance of a multidisciplinary clinical approach to ensure multiple and alternative treatment options. The increase in survival, with the decrease in mortality, suggests an effect of radical treatments on prognosis.

Original languageEnglish
Pages (from-to)91-98
Number of pages8
JournalEuropean Journal of Cancer
Volume67
DOIs
Publication statusPublished - Nov 1 2016

Fingerprint

Prostatic Neoplasms
Population
Survival
Therapeutics
Italy
Mortality
Prostatectomy
Developed Countries
Observational Studies
Registries
Radiotherapy
Retrospective Studies
Incidence
Neoplasms

Keywords

  • Clinical presentation
  • Population-based cancer registries
  • Prostate cancer
  • Survival
  • Treatments

ASJC Scopus subject areas

  • Medicine(all)
  • Oncology
  • Cancer Research

Cite this

Prostate cancer changes in clinical presentation and treatments in two decades : an Italian population-based study. / Trama, Annalisa; Botta, Laura; Nicolai, Nicola; Giorgi Rossi, Paolo; Contiero, Paolo; Fusco, M.; Lodde, Michele; Pannozzo, F.; Piffer, S.; Puppo, Antonella; Seeber, Andreas; Tumino, Rosario; Valdagni, Riccardo; Gatta, Gemma.

In: European Journal of Cancer, Vol. 67, 01.11.2016, p. 91-98.

Research output: Contribution to journalArticle

@article{b03c78df490741bfa95a7f3b1fd04c3b,
title = "Prostate cancer changes in clinical presentation and treatments in two decades: an Italian population-based study",
abstract = "Introduction The incidence of prostate cancer is on the rise in many industrialised countries, including Italy, most likely because of the spread of PSA testing. In Italy, prostate cancer mortality has been dropping since 2000, but it is difficult to understand whether PSA testing is the main reason, considering the role of treatment in prognosis. The objectives of this study were: (1) to describe Italian trends of prostate cancer risk categories and corresponding changes in treatment patterns and (2) to interpret changes in survival over time. Methods We made a retrospective observational study using population-based cancer registries. We examined two periods, 1996–1999 and 2005–2007, analysing the distribution of patients among risk groups and treatment changes in those intervals. We estimated 7- and 15-year relative survival with the cohort approach, Ederer II method. We analysed 4635 cases. Results There was downward risk migration from the first to the second period. In patients younger than 75 years, there was an increase in radical prostatectomy but not radiotherapy; patients older than 75 years rarely had treatment with radical intent. We noted an improvement of prostate cancer survival in the high-risk group. Conclusion These findings raise several questions: the possible overtreatment of low-risk patients undergoing radical treatment; the utility of more aggressive treatment for elderly patients with high-risk disease; and the importance of a multidisciplinary clinical approach to ensure multiple and alternative treatment options. The increase in survival, with the decrease in mortality, suggests an effect of radical treatments on prognosis.",
keywords = "Clinical presentation, Population-based cancer registries, Prostate cancer, Survival, Treatments",
author = "Annalisa Trama and Laura Botta and Nicola Nicolai and {Giorgi Rossi}, Paolo and Paolo Contiero and M. Fusco and Michele Lodde and F. Pannozzo and S. Piffer and Antonella Puppo and Andreas Seeber and Rosario Tumino and Riccardo Valdagni and Gemma Gatta",
year = "2016",
month = "11",
day = "1",
doi = "10.1016/j.ejca.2016.07.021",
language = "English",
volume = "67",
pages = "91--98",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - Prostate cancer changes in clinical presentation and treatments in two decades

T2 - an Italian population-based study

AU - Trama, Annalisa

AU - Botta, Laura

AU - Nicolai, Nicola

AU - Giorgi Rossi, Paolo

AU - Contiero, Paolo

AU - Fusco, M.

AU - Lodde, Michele

AU - Pannozzo, F.

AU - Piffer, S.

AU - Puppo, Antonella

AU - Seeber, Andreas

AU - Tumino, Rosario

AU - Valdagni, Riccardo

AU - Gatta, Gemma

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Introduction The incidence of prostate cancer is on the rise in many industrialised countries, including Italy, most likely because of the spread of PSA testing. In Italy, prostate cancer mortality has been dropping since 2000, but it is difficult to understand whether PSA testing is the main reason, considering the role of treatment in prognosis. The objectives of this study were: (1) to describe Italian trends of prostate cancer risk categories and corresponding changes in treatment patterns and (2) to interpret changes in survival over time. Methods We made a retrospective observational study using population-based cancer registries. We examined two periods, 1996–1999 and 2005–2007, analysing the distribution of patients among risk groups and treatment changes in those intervals. We estimated 7- and 15-year relative survival with the cohort approach, Ederer II method. We analysed 4635 cases. Results There was downward risk migration from the first to the second period. In patients younger than 75 years, there was an increase in radical prostatectomy but not radiotherapy; patients older than 75 years rarely had treatment with radical intent. We noted an improvement of prostate cancer survival in the high-risk group. Conclusion These findings raise several questions: the possible overtreatment of low-risk patients undergoing radical treatment; the utility of more aggressive treatment for elderly patients with high-risk disease; and the importance of a multidisciplinary clinical approach to ensure multiple and alternative treatment options. The increase in survival, with the decrease in mortality, suggests an effect of radical treatments on prognosis.

AB - Introduction The incidence of prostate cancer is on the rise in many industrialised countries, including Italy, most likely because of the spread of PSA testing. In Italy, prostate cancer mortality has been dropping since 2000, but it is difficult to understand whether PSA testing is the main reason, considering the role of treatment in prognosis. The objectives of this study were: (1) to describe Italian trends of prostate cancer risk categories and corresponding changes in treatment patterns and (2) to interpret changes in survival over time. Methods We made a retrospective observational study using population-based cancer registries. We examined two periods, 1996–1999 and 2005–2007, analysing the distribution of patients among risk groups and treatment changes in those intervals. We estimated 7- and 15-year relative survival with the cohort approach, Ederer II method. We analysed 4635 cases. Results There was downward risk migration from the first to the second period. In patients younger than 75 years, there was an increase in radical prostatectomy but not radiotherapy; patients older than 75 years rarely had treatment with radical intent. We noted an improvement of prostate cancer survival in the high-risk group. Conclusion These findings raise several questions: the possible overtreatment of low-risk patients undergoing radical treatment; the utility of more aggressive treatment for elderly patients with high-risk disease; and the importance of a multidisciplinary clinical approach to ensure multiple and alternative treatment options. The increase in survival, with the decrease in mortality, suggests an effect of radical treatments on prognosis.

KW - Clinical presentation

KW - Population-based cancer registries

KW - Prostate cancer

KW - Survival

KW - Treatments

UR - http://www.scopus.com/inward/record.url?scp=84986268742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84986268742&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2016.07.021

DO - 10.1016/j.ejca.2016.07.021

M3 - Article

VL - 67

SP - 91

EP - 98

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

ER -